Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

D. B. Evans, T. A. Rich, D. R. Byrd, K. R. Cleary, J. H. Connelly, B. Levin, C. Charnsangavej, C. J. Fenoglio and F. C. Ames
Department of General Surgery, University of Texas M. D. Anderson Cancer Center, Houston 77030.

Chemoradiation prior to pancreaticoduodenectomy ensures that all patients who undergo resection complete multimodality therapy, avoids resection in patients with rapidly progressive disease, and allows radiation therapy to be delivered to well-oxygenated cells before surgical devascularization. Twenty-eight patients with cytologic or histologic proof of localized adenocarcinoma of the pancreatic head received preoperative chemoradiation (fluorouracil, 300 mg/m2 per day, and 50.4 Gy) with the intent of proceeding to resection; all 28 completed this preoperative therapy. Hospital admission because of gastrointestinal toxic effects was required in nine patients, yet no patient experienced a delay in operation. Restaging was performed 4 to 5 weeks after completion of chemoradiation, and five patients were found to have metastatic disease; the 23 patients without evidence of progressive disease underwent laparotomy. At laparotomy, three patients were found to have unsuspected metastatic disease, three patients had unresectable locally advanced disease, and 17 patients were able to undergo pancreaticoduodenectomy. One perioperative death resulted from myocardial infarction, and perioperative complications occurred in three patients. Histologic evidence of tumor cell injury was present in all resected specimens. Our results suggest that pancreaticoduodenectomy can be performed with a low incidence of complications after chemoradiation for localized adenocarcinoma of the pancreas.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adjuvant Therapy for Adenocarcinoma of the Pancreas: Analysis of Reported Trials and Recommendations for Future Progress
Wolff et al.
Ann. Surg. Oncol. 2008;15:2773-2786.
ABSTRACT | FULL TEXT  

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head
Varadhachary et al.
JCO 2008;26:3487-3495.
ABSTRACT | FULL TEXT  

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head
Evans et al.
JCO 2008;26:3496-3502.
ABSTRACT | FULL TEXT  

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head
Heinrich et al.
JCO 2008;26:2526-2531.
ABSTRACT | FULL TEXT  

Single-Nucleotide Polymorphisms of DNA Damage Response Genes Are Associated with Overall Survival in Patients with Pancreatic Cancer
Okazaki et al.
Clin. Cancer Res. 2008;14:2042-2048.
ABSTRACT | FULL TEXT  

Phase I Study of Oxaliplatin, Full-Dose Gemcitabine, and Concurrent Radiation Therapy in Pancreatic Cancer
Desai et al.
JCO 2007;25:4587-4592.
ABSTRACT | FULL TEXT  

Complications Associated with Neoadjuvant Radiotherapy in the Multidisciplinary Treatment of Retroperitoneal Sarcomas
Caudle et al.
Ann. Surg. Oncol. 2007;14:577-582.
ABSTRACT | FULL TEXT  

Single Nucleotide Polymorphisms of RecQ1, RAD54L, and ATM Genes Are Associated With Reduced Survival of Pancreatic Cancer
Li et al.
JCO 2006;24:1720-1728.
ABSTRACT | FULL TEXT  

Phase I Trial Evaluating the Safety of Bevacizumab With Concurrent Radiotherapy and Capecitabine in Locally Advanced Pancreatic Cancer
Crane et al.
JCO 2006;24:1145-1151.
ABSTRACT | FULL TEXT  

Pathologic Nodal Status Predicts Disease-Free Survival After Neoadjuvant Chemoradiation for Gastroesophageal Junction Carcinoma
Gaca et al.
Ann. Surg. Oncol. 2006;13:340-346.
ABSTRACT | FULL TEXT  

A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma
Talamonti et al.
Ann. Surg. Oncol. 2006;13:150-158.
ABSTRACT | FULL TEXT  

Docetaxel/Gemcitabine Followed by Gemcitabine and External Beam Radiotherapy in Patients With Pancreatic Adenocarcinoma
Pipas et al.
Ann. Surg. Oncol. 2005;12:995-1004.
ABSTRACT | FULL TEXT  

Multimodality Approaches for Pancreatic Cancer
Yang et al.
CA Cancer J Clin 2005;55:352-367.
ABSTRACT | FULL TEXT  

Feasibility and Efficacy of Combination Therapy With Preoperative and Postoperative Chemoradiation, Extended Pancreatectomy, and Postoperative Liver Perfusion Chemotherapy for Locally Advanced Cancers of the Pancreatic Head
Ohigashi et al.
Ann. Surg. Oncol. 2005;12:629-636.
ABSTRACT | FULL TEXT  

Case 20-2005 - A 58-Year-Old Man with Locally Advanced Pancreatic Cancer
Ryan et al.
NEJM 2005;352:2734-2741.
FULL TEXT  

Significance of Histological Response to Preoperative Chemoradiotherapy for Pancreatic Cancer
White et al.
Ann. Surg. Oncol. 2005;12:214-221.
ABSTRACT | FULL TEXT  

Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome
T. Pisters et al.
JCO 2002;20:2537-2544.
ABSTRACT | FULL TEXT  

Localized Adenocarcinoma of the Pancreas: The Rationale for Preoperative Chemoradiation
Wayne et al.
The Oncologist 2002;7:34-45.
ABSTRACT | FULL TEXT  

Neoadjuvant Chemoradiation for Localized Adenocarcinoma of the Pancreas: Great Logic, Grim Reality
Wolff
Ann. Surg. Oncol. 2001;8:747-748.
FULL TEXT  

Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer
McGinn et al.
JCO 2001;19:4202-4208.
ABSTRACT | FULL TEXT  

A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Lowy et al.
Ann. Surg. Oncol. 2001;8:519-524.
ABSTRACT | FULL TEXT  

Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration
Breslin et al.
Ann. Surg. Oncol. 2001;8:123-132.
ABSTRACT | FULL TEXT  

Preoperative Chemoradiation for Patients With Pancreatic Cancer: Toxicity of Endobiliary Stents
Pisters et al.
JCO 2000;18:860-860.
ABSTRACT | FULL TEXT  

Preoperative Chemotherapy, Radiotherapy, and Surgical Resection of Locally Advanced Pancreatic Cancer
Wanebo et al.
Arch Surg 2000;135:81-87.
ABSTRACT | FULL TEXT  

Pancreatic Cancer: Local Success and Distant Failure
Ryan and Grossbard
The Oncologist 1998;3:178-188.
ABSTRACT | FULL TEXT